Last filing: May 11, 2026.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Charles River Laboratories (CRL) | Director | Jul 7, 2017 | May 11, 2026 |
| Kailera Therapeutics, Inc. (KLRA) | Director | Apr 16, 2026 | Apr 20, 2026 |
| Pfizer (PFE) | Former Senior Vice President | Oct 12, 2007 | May 18, 2010 |
Also a director at
Recent filings
The last day with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- May 8, 2026, Charles River Laboratories: 2,845 shares awarded. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.